tiprankstipranks
Trending News
More News >
Quest Diagnostics (DGX)
NYSE:DGX
US Market

Quest Diagnostics (DGX) Financial Statements

Compare
989 Followers

Quest Diagnostics Financial Overview

Quest Diagnostics's market cap is currently $23.28B. The company's EPS TTM is $2.42; its P/E ratio is 24.24; and it has a dividend yield of 1.80%. Quest Diagnostics is scheduled to report earnings on February 10, 2026, and the estimated EPS forecast is $2.37. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue$ 11.04B$ 9.87B$ 9.25B$ 9.88B$ 10.79B
Gross Profit$ 3.52B$ 3.24B$ 3.07B$ 3.43B$ 4.21B
Operating Income$ 1.60B$ 1.35B$ 1.26B$ 1.43B$ 2.38B
EBITDA$ 2.19B$ 1.89B$ 1.73B$ 1.82B$ 3.16B
Net Income$ 992.00M$ 871.00M$ 854.00M$ 946.00M$ 2.00B
Balance Sheet
Cash & Short-Term Investments$ 420.00M$ 549.00M$ 686.00M$ 315.00M$ 872.00M
Total Assets$ 16.23B$ 16.15B$ 14.02B$ 12.84B$ 13.61B
Total Debt$ 6.92B$ 7.09B$ 5.50B$ 4.71B$ 4.77B
Net Debt$ 6.50B$ 6.54B$ 4.81B$ 4.40B$ 3.90B
Total Liabilities$ 8.94B$ 9.26B$ 7.60B$ 6.83B$ 7.05B
Stockholders' Equity$ 7.17B$ 6.78B$ 6.31B$ 5.89B$ 6.44B
Cash Flow
Free Cash Flow$ 1.36B$ 909.00M$ 864.00M$ 1.31B$ 1.83B
Operating Cash Flow$ 1.89B$ 1.33B$ 1.27B$ 1.72B$ 2.23B
Investing Cash Flow$ -631.00M$ -2.55B$ -1.06B$ -543.00M$ 21.00M
Financing Cash Flow$ -1.39B$ 1.08B$ 160.00M$ -1.73B$ -2.54B
Currency in USD

Quest Diagnostics Earnings and Revenue History

Quest Diagnostics Debt to Assets

Quest Diagnostics Cash Flow

Quest Diagnostics Forecast EPS vs Actual EPS